Literature DB >> 17373331

Detection of local residual tumor after laryngeal cancer treatment using FDG-PET.

Ai Oe1, Joji Kawabe, Kenji Torii, Etsushi Kawamura, Jin Kotani, Takehiro Hayashi, Hiroko Kurooka, Chikako Tsumoto, Shigeaki Higashiyama, Makoto Kusuki, Hiroyuki Tsushima, Hideo Yamane, Susumu Shiomi.   

Abstract

OBJECTIVE: Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is sometimes used as a means of follow-up after diagnosis and treatment of cancers of the head and neck region. The present study was undertaken to evaluate the ability of FDG-PET to detect local residual tumor after treatment of laryngeal cancer.
METHODS: Thirty-six patients with laryngeal cancer underwent FDG-PET before and after initial treatment. Of these patients, 20 received FDG-PET before treatment and 28 received it after treatment. The relationship between standardized uptake values (SUV) and the presence or absence of local residual tumor was investigated by setting the cut-off value of the SUV using the receiver operating characteristics (ROC) curve.
RESULTS: When the pre-treatment SUV threshold for laryngeal cancer was set at 7.20, the detection of local residual tumor after treatment using FDG-PET had a sensitivity of 77.78%, specificity of 81.82%, false positive rate of 18.18%, false negative rate of 22.22%, accuracy of 80% and a p value of 0.02. When the post-treatment SUV threshold for the larynx was set at 3.35, the test had a sensitivity of 93.75%, specificity of 91.67%, false positive rate of 8.33%, false negative rate of 6.25%, accuracy of 92.86% and a p value of 0.0001.
CONCLUSIONS: FDG-PET was found to be useful for determining the presence of local residual tumor after treatment of laryngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373331     DOI: 10.1007/bf03033994

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  3 in total

1.  Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.

Authors:  Tejpal Gupta; Zubin Master; Sadhana Kannan; Jai Prakash Agarwal; Sarbani Ghsoh-Laskar; Venkatesh Rangarajan; Vedang Murthy; Ashwini Budrukkar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-19       Impact factor: 9.236

2.  Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients?

Authors:  Tarun Kumar Jain; Guman Singh; Sumit Goyal; Ajay Yadav; Dinesh Yadav; Nitin Khunteta; Hemant Malhotra
Journal:  World J Nucl Med       Date:  2021-02-12

Review 3.  Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Authors:  Nam P Nguyen; Alexander Chi; Michael Betz; Fabio Almeida; Paul Vos; Rick Davis; Benjamin Slane; Misty Ceizyk; Dave Abraham; Lexie Smith-Raymond; Michelle Stevie; Siyoung Jang; Steven Gelumbauskas; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.